ACRS SG&A Expenses

Aclaris Therapeutics Inc · SG&A Expenses

ACRS logo

ACRS SG&A Expenses

Latest reported$23.24M
ACRS SG&A Expenses ($1.77M → $23.24M)
High-resolution chart · PNG

ACRS sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aclaris Therapeutics Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
21,972,000
22,203,000
31,098,000
25,133,000
23,619,000
20,530,000
27,827,000
75,646,000
33,109,000
15,091,000
5,328,000
2,026,000
1,769,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.